tomeko

Autosomal dominant neovascular inflammatory vitreoretinopathy

Just diagnosed with Autosomal dominant neovascular inflammatory vitreoretinopathy?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal dominant neovascular inflammatory vitreoretinopathy, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal dominant neovascular inflammatory vitreoretinopathy hub →

Overview

Autosomal dominant neovascular inflammatory vitreoretinopathy is a rare condition. Also known as ADNIV. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal dominant neovascular inflammatory vitreoretinopathy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:329211 · OMIM 193235 · ICD-10 H35.2 · GARD 0017497

Find care for Autosomal dominant neovascular inflammatory vitreoretinopathy

Authoritative references for Autosomal dominant neovascular inflammatory vitreoretinopathy

Common questions

I was just diagnosed with Autosomal dominant neovascular inflammatory vitreoretinopathy — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal dominant neovascular inflammatory vitreoretinopathy, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal dominant neovascular inflammatory vitreoretinopathy?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal dominant neovascular inflammatory vitreoretinopathy, filtered to your area.

Are there clinical trials for Autosomal dominant neovascular inflammatory vitreoretinopathy?

Tomeko shows live, recruiting studies for Autosomal dominant neovascular inflammatory vitreoretinopathy from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com